Effects of extended-release niacin with laropiprant in high-risk patients. (2014)

First Author: HPS2-THRIVE Collaborative Group
Attributed to:  CTSU resubmission: Proposal to increase capacity for methodological improvements in clinical trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa1300955

PubMed Identifier: 25014686

Publication URI: http://europepmc.org/abstract/MED/25014686

Type: Journal Article/Review

Volume: 371

Parent Publication: The New England journal of medicine

Issue: 3

ISSN: 0028-4793